第一作者:
Brayden D,Whitlock
第一单位:
Department of Physiology (B.D.W., Y.M., A.R.O., M.B., D.P.S., E.M.L.), Membrane Protein Disease Research Group (B.D.W., Y.M., M.B., D.P.S., E.M.L.), and Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology (X.C.L., E.M.L.), University of Alberta, Edmonton, Alberta, Canada; Department of Pathology and Molecular Medicine, Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (G.C., S.P.C.C.); Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut (Z.P.L.); and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.W., J.D.S.).
作者:
主题词
人类(Humans);动物(Animals);小鼠(Mice);多药耐药相关蛋白质类(Multidrug Resistance-Associated Proteins);HEK293细胞(HEK293 Cells);砷(Arsenic);二甲胂酸(Cacodylic Acid);种特异性(Species Specificity);生物转运(Biological Transport);砷剂(Arsenicals);有机金属化合物(Organometallic Compounds)
DOI
10.1124/dmd.124.001852
PMID
39313329
发布时间
2025-02-11
- 浏览0

Drug metabolism and disposition
1417-1428页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文